_id
691843363c536f8df23176f2
Ticker
WXXWY
Name
WuXi Biologics (Cayman) Inc
Exchange
PINK
Address
No. 108, Meiliang Road, Wuxi, China, 214092
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.wuxibiologics.com
Description
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and engages in investment and material supplier activities. It has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates. The company was incorporated in 2014 and is headquartered in Wuxi, China.
Last Close
9.08
Volume
168
Current Price
9.14
Change
0.47
Last Updated
2026-01-08T13:01:33.943Z
Image
https://logo.clearbit.com/www.wuxibiologics.com
Ipo Date
-
Market Cap
18927403008
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9982500000000001
Sentiment Sources
4
Current Quarter
2025-06-30
Revenue
9953216000
Cost Of Revenue
5700364000
Gross Profit
4252852000
Operating Expenses
1528599000
Operating Income
2724253000
Interest Expense
-
Pretax Income
3328101000
Net Income
2339266000
Eps
1.1177266720043617
Dividends Per Share
-
Shares Outstanding
2064056991
Income Tax Expense
571490000
EBITDA
3355920000
Operating Margin
27.37058052392312
Total Other Income Expense Net
603848000
Cash
8439058000
Short Term Investments
3157800000
Receivables
7028198000
Inventories
1655042000
Total Current Assets
24446633000
Property Plant Equipment
30175140000
Total Assets
60437387000
Payables
969433000
Short Term Debt
2983608000
Long Term Debt
185140000
Total Liabilities
11372316000
Equity
44952434000
Bs_currency_symbol
CNY
Depreciation
631667000
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
32.75
PB
0.42553665732271584
ROE
5.203869494586211
ROA
3.8705611147616295
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
64
Deep Value Investing Score
7
Defensive Investing Score
7.5
Dividend Investing Score
1.5
Economic Moat Investing Score
7.3
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
1.5
Quality Investing Score
6.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
9953216000
Quarters > 0 > income Statement > cost Of Revenue
5700364000
Quarters > 0 > income Statement > gross Profit
4252852000
Quarters > 0 > income Statement > operating Expenses
1528599000
Quarters > 0 > income Statement > operating Income
2724253000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
3328101000
Quarters > 0 > income Statement > net Income
2339266000
Quarters > 0 > income Statement > eps
1.1177266720043617
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2092878392
Quarters > 0 > income Statement > income Tax Expense
571490000
Quarters > 0 > income Statement > EBITDA
3355920000
Quarters > 0 > income Statement > operating Margin
27.37058052392312
Quarters > 0 > income Statement > total Other Income Expense Net
603848000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
8439058000
Quarters > 0 > balance Sheet > short Term Investments
3157800000
Quarters > 0 > balance Sheet > receivables
7028198000
Quarters > 0 > balance Sheet > inventories
1655042000
Quarters > 0 > balance Sheet > total Current Assets
24446633000
Quarters > 0 > balance Sheet > property Plant Equipment
30175140000
Quarters > 0 > balance Sheet > total Assets
60437387000
Quarters > 0 > balance Sheet > payables
969433000
Quarters > 0 > balance Sheet > short Term Debt
2983608000
Quarters > 0 > balance Sheet > long Term Debt
185140000
Quarters > 0 > balance Sheet > total Liabilities
11372316000
Quarters > 0 > balance Sheet > equity
44952434000
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
2339266000
Quarters > 0 > cash Flow > depreciation
631667000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
1.1177266720043617
Quarters > 0 > ratios > PB
0.42553665732271584
Quarters > 0 > ratios > ROE
5.203869494586211
Quarters > 0 > ratios > ROA
3.8705611147616295
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
64
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
10101157000
Quarters > 1 > income Statement > cost Of Revenue
5800288000
Quarters > 1 > income Statement > gross Profit
4300869000
Quarters > 1 > income Statement > operating Expenses
1146739000
Quarters > 1 > income Statement > operating Income
3154130000
Quarters > 1 > income Statement > interest Expense
157587000
Quarters > 1 > income Statement > pretax Income
2826021000
Quarters > 1 > income Statement > net Income
1857001000
Quarters > 1 > income Statement > eps
0.8786035987036138
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
2113582283
Quarters > 1 > income Statement > income Tax Expense
660960000
Quarters > 1 > income Statement > EBITDA
3956042000
Quarters > 1 > income Statement > operating Margin
31.225432888529504
Quarters > 1 > income Statement > total Other Income Expense Net
-328109000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
8279182000
Quarters > 1 > balance Sheet > short Term Investments
2430609000
Quarters > 1 > balance Sheet > receivables
5786808000
Quarters > 1 > balance Sheet > inventories
1521669000
Quarters > 1 > balance Sheet > total Current Assets
23573191000
Quarters > 1 > balance Sheet > property Plant Equipment
28435374000
Quarters > 1 > balance Sheet > total Assets
56977435000
Quarters > 1 > balance Sheet > payables
747147000
Quarters > 1 > balance Sheet > short Term Debt
2619006000
Quarters > 1 > balance Sheet > long Term Debt
200898000
Quarters > 1 > balance Sheet > total Liabilities
11499866000
Quarters > 1 > balance Sheet > equity
41819209000
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
3335318000
Quarters > 1 > cash Flow > depreciation
653262000
Quarters > 1 > cash Flow > change In Working Capital
-800504000
Quarters > 1 > cash Flow > cash From Operations
3915138000
Quarters > 1 > cash Flow > capital Expenditures
2062237000
Quarters > 1 > cash Flow > cash From Investing
-3559181000
Quarters > 1 > cash Flow > cash From Financing
-1274607000
Quarters > 1 > cash Flow > net Change In Cash
-874346000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.8786035987036138
Quarters > 1 > ratios > PB
0.46194422440223587
Quarters > 1 > ratios > ROE
4.440545491905406
Quarters > 1 > ratios > ROA
3.259186728921722
Quarters > 1 > ratios > FCF
1852901000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.18343453131161114
Quarters > 1 > health Score
73
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
8574214000
Quarters > 2 > income Statement > cost Of Revenue
5224263000
Quarters > 2 > income Statement > gross Profit
3349951000
Quarters > 2 > income Statement > operating Expenses
1530277000
Quarters > 2 > income Statement > operating Income
1819674000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
2008377000
Quarters > 2 > income Statement > net Income
1499080000
Quarters > 2 > income Statement > eps
0.7044785253196163
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
2127928597
Quarters > 2 > income Statement > income Tax Expense
228067000
Quarters > 2 > income Statement > EBITDA
2472997000
Quarters > 2 > income Statement > operating Margin
21.222633351581848
Quarters > 2 > income Statement > total Other Income Expense Net
188703000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
9153528000
Quarters > 2 > balance Sheet > short Term Investments
375155000
Quarters > 2 > balance Sheet > receivables
6179282000
Quarters > 2 > balance Sheet > inventories
1962544000
Quarters > 2 > balance Sheet > total Current Assets
19816741000
Quarters > 2 > balance Sheet > property Plant Equipment
30775729000
Quarters > 2 > balance Sheet > total Assets
56105719000
Quarters > 2 > balance Sheet > payables
874530000
Quarters > 2 > balance Sheet > short Term Debt
1085194000
Quarters > 2 > balance Sheet > long Term Debt
1264296000
Quarters > 2 > balance Sheet > total Liabilities
11464904000
Quarters > 2 > balance Sheet > equity
40655213000
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
1499080000
Quarters > 2 > cash Flow > depreciation
783792000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
1302119000
Quarters > 2 > cash Flow > capital Expenditures
1867384000
Quarters > 2 > cash Flow > cash From Investing
-382525000
Quarters > 2 > cash Flow > cash From Financing
-1475584000
Quarters > 2 > cash Flow > net Change In Cash
9153528000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.7044785253196163
Quarters > 2 > ratios > PB
0.47839541208602204
Quarters > 2 > ratios > ROE
3.6873008142891788
Quarters > 2 > ratios > ROA
2.6718844829347965
Quarters > 2 > ratios > FCF
-565265000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
-0.06592615952902506
Quarters > 2 > health Score
55
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
8542209000
Quarters > 3 > income Statement > cost Of Revenue
5274942000
Quarters > 3 > income Statement > gross Profit
3267267000
Quarters > 3 > income Statement > operating Expenses
1621304000
Quarters > 3 > income Statement > operating Income
1645963000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
1644827000
Quarters > 3 > income Statement > net Income
1133054000
Quarters > 3 > income Statement > eps
0.5211956114186347
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2173951536
Quarters > 3 > income Statement > income Tax Expense
412063000
Quarters > 3 > income Statement > EBITDA
2266525000
Quarters > 3 > income Statement > operating Margin
19.268587317402325
Quarters > 3 > income Statement > total Other Income Expense Net
-1136000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
9669839000
Quarters > 3 > balance Sheet > short Term Investments
1573598000
Quarters > 3 > balance Sheet > receivables
6184425000
Quarters > 3 > balance Sheet > inventories
1765751000
Quarters > 3 > balance Sheet > total Current Assets
21198249000
Quarters > 3 > balance Sheet > property Plant Equipment
29939471000
Quarters > 3 > balance Sheet > total Assets
56575726000
Quarters > 3 > balance Sheet > payables
833266000
Quarters > 3 > balance Sheet > short Term Debt
731308000
Quarters > 3 > balance Sheet > long Term Debt
1571046000
Quarters > 3 > balance Sheet > total Liabilities
12557844000
Quarters > 3 > balance Sheet > equity
40331597000
Quarters > 3 > balance Sheet > currency_symbol
CNY
Quarters > 3 > cash Flow > net Income
1699864500
Quarters > 3 > cash Flow > depreciation
584688000
Quarters > 3 > cash Flow > change In Working Capital
-448172500
Quarters > 3 > cash Flow > cash From Operations
2333856000
Quarters > 3 > cash Flow > capital Expenditures
2115257000
Quarters > 3 > cash Flow > cash From Investing
-1614133000
Quarters > 3 > cash Flow > cash From Financing
2149207000
Quarters > 3 > cash Flow > net Change In Cash
3274617000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.5211956114186347
Quarters > 3 > ratios > PB
0.4926637801880248
Quarters > 3 > ratios > ROE
2.809345734561416
Quarters > 3 > ratios > ROA
2.002721096323183
Quarters > 3 > ratios > FCF
218599000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.025590453242246822
Quarters > 3 > health Score
55
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
18675371000
Annuals > 0 > income Statement > cost Of Revenue
11024551000
Annuals > 0 > income Statement > gross Profit
7650820000
Annuals > 0 > income Statement > operating Expenses
2677016000
Annuals > 0 > income Statement > operating Income
4973804000
Annuals > 0 > income Statement > interest Expense
157587000
Annuals > 0 > income Statement > pretax Income
4834398000
Annuals > 0 > income Statement > net Income
3356081000
Annuals > 0 > income Statement > eps
1.5771586531293746
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
2127928597
Annuals > 0 > income Statement > income Tax Expense
889027000
Annuals > 0 > income Statement > EBITDA
6429039000
Annuals > 0 > income Statement > operating Margin
26.632959527283283
Annuals > 0 > income Statement > total Other Income Expense Net
-139406000
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
8279182000
Annuals > 0 > balance Sheet > short Term Investments
2430609000
Annuals > 0 > balance Sheet > receivables
5786808000
Annuals > 0 > balance Sheet > inventories
1521669000
Annuals > 0 > balance Sheet > total Current Assets
23573191000
Annuals > 0 > balance Sheet > property Plant Equipment
28435374000
Annuals > 0 > balance Sheet > total Assets
56977435000
Annuals > 0 > balance Sheet > payables
747147000
Annuals > 0 > balance Sheet > short Term Debt
2619006000
Annuals > 0 > balance Sheet > long Term Debt
200898000
Annuals > 0 > balance Sheet > total Liabilities
11499866000
Annuals > 0 > balance Sheet > equity
41819209000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
4834398000
Annuals > 0 > cash Flow > depreciation
1437054000
Annuals > 0 > cash Flow > change In Working Capital
-800504000
Annuals > 0 > cash Flow > cash From Operations
5217257000
Annuals > 0 > cash Flow > capital Expenditures
3929621000
Annuals > 0 > cash Flow > cash From Investing
-3941706000
Annuals > 0 > cash Flow > cash From Financing
-2750191000
Annuals > 0 > cash Flow > net Change In Cash
-1390657000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
1.5771586531293746
Annuals > 0 > ratios > PB
0.4650797526222938
Annuals > 0 > ratios > ROE
8.02521396327702
Annuals > 0 > ratios > ROA
5.89019319665759
Annuals > 0 > ratios > FCF
1287636000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.06894834913855259
Annuals > 0 > health Score
67
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
17034255000
Annuals > 1 > income Statement > cost Of Revenue
10206354000
Annuals > 1 > income Statement > gross Profit
6827901000
Annuals > 1 > income Statement > operating Expenses
2377704000
Annuals > 1 > income Statement > operating Income
4450197000
Annuals > 1 > income Statement > interest Expense
158488000
Annuals > 1 > income Statement > pretax Income
4173803000
Annuals > 1 > income Statement > net Income
3399729000
Annuals > 1 > income Statement > eps
1.563498333740595
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2174437239
Annuals > 1 > income Statement > income Tax Expense
603179000
Annuals > 1 > income Statement > EBITDA
5501667000
Annuals > 1 > income Statement > operating Margin
26.124987561827623
Annuals > 1 > income Statement > total Other Income Expense Net
-276394000
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
9669839000
Annuals > 1 > balance Sheet > short Term Investments
1573598000
Annuals > 1 > balance Sheet > receivables
6247993000
Annuals > 1 > balance Sheet > inventories
1765751000
Annuals > 1 > balance Sheet > total Current Assets
21198249000
Annuals > 1 > balance Sheet > property Plant Equipment
29939471000
Annuals > 1 > balance Sheet > total Assets
56575726000
Annuals > 1 > balance Sheet > payables
833266000
Annuals > 1 > balance Sheet > short Term Debt
731308000
Annuals > 1 > balance Sheet > long Term Debt
1571046000
Annuals > 1 > balance Sheet > total Liabilities
12557844000
Annuals > 1 > balance Sheet > equity
40331597000
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
3399729000
Annuals > 1 > cash Flow > depreciation
1169376000
Annuals > 1 > cash Flow > change In Working Capital
-896345000
Annuals > 1 > cash Flow > cash From Operations
4667712000
Annuals > 1 > cash Flow > capital Expenditures
4230514000
Annuals > 1 > cash Flow > cash From Investing
-3228266000
Annuals > 1 > cash Flow > cash From Financing
1961163000
Annuals > 1 > cash Flow > net Change In Cash
3274617000
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
1.563498333740595
Annuals > 1 > ratios > PB
0.4927738508460253
Annuals > 1 > ratios > ROE
8.429443049329288
Annuals > 1 > ratios > ROA
6.009165485565311
Annuals > 1 > ratios > FCF
437198000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.02566581279897477
Annuals > 1 > health Score
63
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
15268660000
Annuals > 2 > income Statement > cost Of Revenue
8544646000
Annuals > 2 > income Statement > gross Profit
6724014000
Annuals > 2 > income Statement > operating Expenses
2382092000
Annuals > 2 > income Statement > operating Income
4350166000
Annuals > 2 > income Statement > interest Expense
64382000
Annuals > 2 > income Statement > pretax Income
5357771000
Annuals > 2 > income Statement > net Income
4420286000
Annuals > 2 > income Statement > eps
2.0202829260099975
Annuals > 2 > income Statement > dividends Per Share
5452489000
Annuals > 2 > income Statement > shares Outstanding
2187953946
Annuals > 2 > income Statement > income Tax Expense
807865000
Annuals > 2 > income Statement > EBITDA
5068796000
Annuals > 2 > income Statement > operating Margin
28.49081713784969
Annuals > 2 > income Statement > total Other Income Expense Net
1015849000
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
6395222000
Annuals > 2 > balance Sheet > short Term Investments
304469000
Annuals > 2 > balance Sheet > receivables
5158395000
Annuals > 2 > balance Sheet > inventories
2280911000
Annuals > 2 > balance Sheet > total Current Assets
18469868000
Annuals > 2 > balance Sheet > property Plant Equipment
25915998000
Annuals > 2 > balance Sheet > total Assets
49564385000
Annuals > 2 > balance Sheet > payables
794388000
Annuals > 2 > balance Sheet > short Term Debt
1470488000
Annuals > 2 > balance Sheet > long Term Debt
1461563000
Annuals > 2 > balance Sheet > total Liabilities
13351308000
Annuals > 2 > balance Sheet > equity
35047407000
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
4420286000
Annuals > 2 > cash Flow > depreciation
833034000
Annuals > 2 > cash Flow > change In Working Capital
-2098197000
Annuals > 2 > cash Flow > cash From Operations
5541673000
Annuals > 2 > cash Flow > capital Expenditures
5868390000
Annuals > 2 > cash Flow > cash From Investing
-5908252000
Annuals > 2 > cash Flow > cash From Financing
-2591592000
Annuals > 2 > cash Flow > net Change In Cash
-2608058000
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
2.0202829260099975
Annuals > 2 > ratios > PB
0.570595681056804
Annuals > 2 > ratios > ROE
12.612305383961786
Annuals > 2 > ratios > ROA
8.91827064937858
Annuals > 2 > ratios > FCF
-326717000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
-0.02139788298383748
Annuals > 2 > health Score
69
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
10290050000
Annuals > 3 > income Statement > cost Of Revenue
5461153000
Annuals > 3 > income Statement > gross Profit
4828897000
Annuals > 3 > income Statement > operating Expenses
1640786000
Annuals > 3 > income Statement > operating Income
3188111000
Annuals > 3 > income Statement > interest Expense
39191000
Annuals > 3 > income Statement > pretax Income
3993119000
Annuals > 3 > income Statement > net Income
3388478000
Annuals > 3 > income Statement > eps
1.532624881050225
Annuals > 3 > income Statement > dividends Per Share
7696084000
Annuals > 3 > income Statement > shares Outstanding
2210898467
Annuals > 3 > income Statement > income Tax Expense
484538000
Annuals > 3 > income Statement > EBITDA
3622310000
Annuals > 3 > income Statement > operating Margin
30.98246364206199
Annuals > 3 > income Statement > total Other Income Expense Net
805008000
Annuals > 3 > income Statement > currency_symbol
CNY
Annuals > 3 > balance Sheet > cash
9003280000
Annuals > 3 > balance Sheet > short Term Investments
1147626000
Annuals > 3 > balance Sheet > receivables
3273111000
Annuals > 3 > balance Sheet > inventories
1687375000
Annuals > 3 > balance Sheet > total Current Assets
19529741000
Annuals > 3 > balance Sheet > property Plant Equipment
19755796000
Annuals > 3 > balance Sheet > total Assets
44032623000
Annuals > 3 > balance Sheet > payables
617784000
Annuals > 3 > balance Sheet > short Term Debt
2225456000
Annuals > 3 > balance Sheet > long Term Debt
640513000
Annuals > 3 > balance Sheet > total Liabilities
11326457000
Annuals > 3 > balance Sheet > equity
32278593000
Annuals > 3 > balance Sheet > currency_symbol
CNY
Annuals > 3 > cash Flow > net Income
3388478000
Annuals > 3 > cash Flow > depreciation
572271000
Annuals > 3 > cash Flow > change In Working Capital
-2775870000
Annuals > 3 > cash Flow > cash From Operations
3431258000
Annuals > 3 > cash Flow > capital Expenditures
6507803000
Annuals > 3 > cash Flow > cash From Investing
-9601670000
Annuals > 3 > cash Flow > cash From Financing
8209459000
Annuals > 3 > cash Flow > net Change In Cash
1907545000
Annuals > 3 > cash Flow > currency_symbol
CNY
Annuals > 3 > ratios > PE
1.532624881050225
Annuals > 3 > ratios > PB
0.626037571971616
Annuals > 3 > ratios > ROE
10.497601304988727
Annuals > 3 > ratios > ROA
7.695380763485292
Annuals > 3 > ratios > FCF
-3076545000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
-0.2989825122326908
Annuals > 3 > health Score
66
Valuation > metrics > PE
32.75
Valuation > metrics > PB
0.42553665732271584
Valuation > final Score
60.7
Valuation > verdict
13.2% Undervalued
Profitability > metrics > ROE
5.203869494586211
Profitability > metrics > ROA
9.568867827320023
Profitability > metrics > Net Margin
0.23502614632295732
Profitability > final Score
69
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.2529855446759568
Risk > metrics > Interest Coverage
97.92778316977605
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
6.184259915341126
Liquidity > metrics > Quick Ratio
5.765584267909187
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
60
Prev Profitabilities > 1
56
Prev Profitabilities > 2
42
Prev Risks > 0
100
Prev Risks > 1
76
Prev Risks > 2
71
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:50:27.628Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-23
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-12-03
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-22
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.55
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.55
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-28
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-25
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.44
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0.44
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-27
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-21
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-03-31
Earnings History > 7 > report Date
2021-06-30
Earnings History > 7 > date
2021-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CNY
Earnings History > 7 > eps Actual
0.0325
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.0325
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-12-31
Earnings History > 8 > report Date
2021-03-31
Earnings History > 8 > date
2020-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CNY
Earnings History > 8 > eps Actual
0.032
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0.032
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-09-30
Earnings History > 9 > report Date
2020-12-31
Earnings History > 9 > date
2020-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CNY
Earnings History > 9 > eps Actual
0.0171
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.0171
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-06-30
Earnings History > 10 > report Date
2020-09-30
Earnings History > 10 > date
2020-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CNY
Earnings History > 10 > eps Actual
0.0164
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.0164
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-03-31
Earnings History > 11 > report Date
2020-06-30
Earnings History > 11 > date
2020-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CNY
Earnings History > 11 > eps Actual
0.0127
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.0127
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2019-12-31
Earnings History > 12 > report Date
2020-03-31
Earnings History > 12 > date
2019-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CNY
Earnings History > 12 > eps Actual
0.0127
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.0127
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2019-09-30
Earnings History > 13 > report Date
2019-12-31
Earnings History > 13 > date
2019-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CNY
Earnings History > 13 > eps Actual
0.0098
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.0098
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2019-06-30
Earnings History > 14 > report Date
2019-09-30
Earnings History > 14 > date
2019-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
CNY
Earnings History > 14 > eps Actual
0.0096
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0.0096
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2019-03-31
Earnings History > 15 > report Date
2019-06-30
Earnings History > 15 > date
2019-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
CNY
Earnings History > 15 > eps Actual
0.0082
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.0082
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2018-12-31
Earnings History > 16 > report Date
2019-03-31
Earnings History > 16 > date
2018-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
CNY
Earnings History > 16 > eps Actual
0.0084
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0.0084
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2018-09-30
Earnings History > 17 > report Date
2018-12-31
Earnings History > 17 > date
2018-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
CNY
Earnings History > 17 > eps Actual
0.007
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0.007
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2018-06-30
Earnings History > 18 > report Date
2018-09-30
Earnings History > 18 > date
2018-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
CNY
Earnings History > 18 > eps Actual
0.007
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0.007
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2018-03-31
Earnings History > 19 > report Date
2018-06-30
Earnings History > 19 > date
2018-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
CNY
Earnings History > 19 > eps Actual
0.0048
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0.0048
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2017-12-31
Earnings History > 20 > report Date
2018-03-31
Earnings History > 20 > date
2017-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
CNY
Earnings History > 20 > eps Actual
0.005
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0.005
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2017-09-30
Earnings History > 21 > report Date
2017-12-31
Earnings History > 21 > date
2017-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
CNY
Earnings History > 21 > eps Actual
0.0032
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0.0032
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2017-06-30
Earnings History > 22 > report Date
2017-09-30
Earnings History > 22 > date
2017-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
CNY
Earnings History > 22 > eps Actual
0.0032
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0.0032
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2017-03-31
Earnings History > 23 > report Date
2017-06-30
Earnings History > 23 > date
2017-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
CNY
Earnings History > 23 > eps Actual
0.0022
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0.0022
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2016-12-31
Earnings History > 24 > report Date
2017-03-31
Earnings History > 24 > date
2016-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
CNY
Earnings History > 24 > eps Actual
0.0022
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0.0022
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2016-09-30
Earnings History > 25 > report Date
2016-12-31
Earnings History > 25 > date
2016-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
CNY
Earnings History > 25 > eps Actual
0.0002
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
0.0002
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2016-03-31
Earnings History > 26 > report Date
2016-06-30
Earnings History > 26 > date
2016-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
CNY
Earnings History > 26 > eps Actual
0.0022
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0.0022
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2015-12-31
Earnings History > 27 > report Date
2016-03-31
Earnings History > 27 > date
2015-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
CNY
Earnings History > 27 > eps Actual
0.0022
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
0.0022
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2015-09-30
Earnings History > 28 > report Date
2015-12-31
Earnings History > 28 > date
2015-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
CNY
Earnings History > 28 > eps Actual
0.0019
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
0.0019
Earnings History > 28 > surprise Percent
-
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and engages in investment and material supplier activities. It has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates. The company was incorporated in 2014 and is headquartered in Wuxi, China.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Sees Large Growth in Short Interest - Defense World
1/16/2026
WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Sees Large Growth in Short Interest Defense World
Read more →8.0 g/L Antibody Yield: WuXi Biologics' New TrueSite Platform Cuts Drug Development to 6 Months Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Medium
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of WuXi Biologics (Cayman) Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.